Literature DB >> 1336678

The role of hepatitis B virus in the development of primary hepatocellular carcinoma: Part I.

W S Robinson1.   

Abstract

Chronic infections with hepatitis B virus (HBV) of humans and animal hepadnavirus infections in their natural hosts are strongly associated with primary hepatocellular carcinoma (HCC). Although viral integrations are found in cells of many HCC, no general viral-specific hepatocarcinogenic mechanism for hepadnaviruses has been identified. In approximately one half of HCC in woodchuck hepatitis virus (WHV) infected woodchucks, viral integrations near the c-myc or N-myc genes have been reported which result in enhanced expression of the respective gene. Such host gene-specific insertional mutagenesis has not been found in HCC of other hepadnavirus infected hosts. Thus in humans, ground squirrels and ducks hepadnaviral integrations appear to be at different host chromosomal DNA sites in each HCC and few integrations have been found within or near any cellular gene. Other possible hepadnavirus-specific carcinogenic mechanisms that are being investigated include transactivation of cellular gene expression by an hepadnavirus gene product (e.g. the X-gene), and mutation of host genes by unknown hepadnavirus-specific mechanisms. It should be noted, however, that chronic hepadnavirus infection is associated with chronic necroinflammatory liver disease with hepatocellular necrosis and regeneration (sometimes leading to cirrhosis in humans), a pathological process that is common to numerous other risk factors for HCC. This suggests the possibility that this pathological process is hepatocarcinogenic irrespective of the inciting agent and the role of hepadnavirus infection is no different from that of other risk factors in causing chronic necroinflammatory liver disease.

Entities:  

Mesh:

Year:  1992        PMID: 1336678     DOI: 10.1111/j.1440-1746.1992.tb01497.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Analysis of point mutation in site 1896 of HBV precore and its detection in the tissues and serum of HCC patients.

Authors:  Yuan Wang; Hu Liu; Qing Zhou; Xu Li
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Detection of promoter methylation status of suppressor of cytokine signaling 3 (SOCS3) in tissue and plasma from Chinese patients with different hepatic diseases.

Authors:  Ling Wei; Yuan Huang; Rongce Zhao; Jing Zhang; Qiuying Liu; Weibo Liang; Xueqin Ding; Bo Gao; Bo Li; Chengjun Sun; Jingyang He; Xiaoqin Yu; Zhongjian Liu; Aimin Sun; Yang Qin
Journal:  Clin Exp Med       Date:  2017-09-26       Impact factor: 3.984

3.  Analysis of DNA methylation in plasma for monitoring hepatocarcinogenesis.

Authors:  Wenqing Huang; Tong Li; Wenli Yang; Xinjuan Chai; Kefei Chen; Ling Wei; Shuwang Duan; Bo Li; Yang Qin
Journal:  Genet Test Mol Biomarkers       Date:  2015-04-29

4.  Hepatitis B testing among Vietnamese American men.

Authors:  Victoria M Taylor; Yutaka Yasui; Nancy Burke; Tung Nguyen; Anthony Chen; Elizabeth Acorda; John H Choe; J Carey Jackson
Journal:  Cancer Detect Prev       Date:  2004

5.  Simultaneous presentation of hepatocellular carcinoma in identical twin brothers.

Authors:  Gokhan Demir; Sedef Belentepe; Mustafa Ozguroglu; Aykut Ferhat Celik; Nur Sayhan; Salim Tekin; Nil Molinas Mandel; Evin Buyukunal; Suheyla Serdengecti
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

6.  Autism-Associated Vigilin Depletion Impairs DNA Damage Repair.

Authors:  Shahid Banday; Raj K Pandita; Arjamand Mushtaq; Albino Bacolla; Ulfat Syed Mir; Dharmendra Kumar Singh; Sadaf Jan; Krishna P Bhat; Clayton R Hunt; Ganesh Rao; Vijay K Charaka; John A Tainer; Tej K Pandita; Mohammad Altaf
Journal:  Mol Cell Biol       Date:  2021-06-23       Impact factor: 4.272

Review 7.  Understanding the role of PIN1 in hepatocellular carcinoma.

Authors:  Chi-Wai Cheng; Ka-Wai Leong; Eric Tse
Journal:  World J Gastroenterol       Date:  2016-12-07       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.